Barriers to patient self-testing of prothrombin time: National survey of anticoagulation practitioners

Pharmacotherapy

Volumn 25, Issue 2, 2005, Pages 265-269

  Wittkowsky, Ann K ^a,d   Sekreta, Colleen M ^a   Nutescu, Edith A ^b   Ansell, Jack ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Barriers; INR; Patient self testing; Point of care devices; Prothrombin time; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULATION; CONTROLLED STUDY; DRUG COST; DRUG SURVEILLANCE PROGRAM; EUROPE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICAL PRACTICE; PROTHROMBIN TIME; REIMBURSEMENT; REVIEW; SELF EVALUATION; SELF MEDICATION; UNITED STATES;

AMBULATORY CARE FACILITIES; ANTICOAGULANTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME; QUESTIONNAIRES; SELF CARE; UNITED STATES; WARFARIN;

EID: 13544273265     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.2.265.56949     Document Type: Review

References (11)

1. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(suppl 1):8-21.
2. White RH, McCurdy SA, Von Marensdorff H, Woodruff DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 1989;111:730-7.
3. Anderson D, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulation therapy. Arch Intern Med 1993;153:1441-7.
4. Beyth RJ, Landefeldt CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med 2000;133:687-95.
5. Sawicki PT. A structured teaching and self management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA 1999;281:145-50.
6. Jacobson AK. The North American experience with patient self-testing of the INR. Semin Vasc Med 2003;3:295-301.
7. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7.
8. Jacobson AK, Guilloteau FR, Campbell PM, Denham CR. Comparison of point of care testing and standard reference laboratory testing for PT/INR in patients receiving routine warfarin therapy: an engineering work process flow study. Dis Manage Clin Outcomes 2000;2:1-8.
9. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost 1999;25:103-7.
10. Gadisseur APA, Breukink-Engbers WGM, van der Meer FJM, van den Besselaar AMH, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in The Netherlands: a randomized clinical trial. Arch Intern Med 2003;163:2639-46.
11. Cromheeke M, Levi M, Colly L, et al. Oral anticoagulation self management and management by a specialized anticoagulation clinic: a randomized cross-over comparison. Lancet 2000;356:97-102.